Background: on 21 October 2026 Digital Health News reported new research funding at the Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram.
What was reported
RGCB has secured a grant of ₹7 crore to develop a blood-based device for cervical cancer detection. The device is at the development stage; it is not an approved test and is not available to clinics or patients.
What this means for your clinic
For gynaecology clinics, nothing changes in practice today: screening continues under current guidelines. If you write about cervical cancer screening for patients, keep it factual and current, explain who should be screened and how often under accepted guidance, and avoid presenting research devices as available. Cancer is among the conditions listed under the Drugs and Magic Remedies Act, so clinic content should never claim to cure or prevent it.
Source: Digital Health News, 21 October 2026. MedDaily briefs are general information, not legal or clinical advice.
